SLC22A6 Rabbit Polyclonal Antibody
CAT#: TA322015
Anti-SLC22A6 Rabbit Polyclonal Antibody
Need it in bulk or conjugated?
Get a free quote
CNY 1,999.00
CNY 3,280.00
Cited in 2 publications. |
CNY 300.00
CNY 1,430.00
CNY 3,080.00
Specifications
Product Data | |
Applications | IHC, WB |
Recommend Dilution | WB: 1000-5000 WB positive control: Human fetal kidney tissue IHC: 50-200 Positive control: Human breast cancer Predicted cell location: Cytoplasm |
Reactivity | Human, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Synthetic peptide corresponding to a region derived from 551-563 amino acids of Human solute carrier family 22 (organic anion transporter), member 6 |
Formulation | PBS pH7.3, 0.05% NaN3, 50% glycerol |
Concentration | lot specific |
Purification | Antigen affinity purification |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 56 kDa |
Gene Name | solute carrier family 22 member 6 |
Database Link | |
Background | The protein encoded by this gene is involved in the sodium-dependent transport and excretion of organic anions; some of which are potentially toxic. The encoded protein is an integral membrane protein and may be localized to the basolateral membrane. Four transcript variants encoding four different isoforms have been found for this gene. Functions as organic anion exchanger when the uptake of one molecule of organic anion is coupled with an efflux of one molecule of endogenous dicarboxylic acid (glutarate; ketoglutarate; etc). Mediates the sodium-independent uptake of 2;3-dimercapto-1-propanesulfonic acid (DMPS) By similarity. |
Synonyms | HOAT1; OAT1; PAHT; ROAT1 |
Reference Data | |
Protein Families | Transmembrane |
Citations (2)
The use of this Antibodies has been cited in the following citations: |
---|
Olsalazine sodium increases renal urate excretion by modulating urate transporters in hyperuricemic animals
,Niu, Y;Yang, P;Li, H;Li, Q;Lin, H;Gao, L;Li, L;,
Biol. Pharm. Bull.
,PubMed ID 32863294
[SLC22A6]
|
Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition
,Lin, H;Tu, C;Niu, Y;Li, F;Yuan, L;Li, N;Xu, A;Gao, L;Li, L;,
Eur. J. Pharmacol.
,PubMed ID 31009635
[SLC22A6]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它SLC22A6产品